C-reactive protein levels correlate with future risk of heart attack, stroke and cancers, but causality seems unlikely

December 21, 2009

There has been intense interest among researchers during the past decade about whether blood concentrations of C-reactive protein (CRP)--a sensitive indicator of tissue injury inflammation produced by the liver--is a causal factor in heart disease. Earlier studies had suggested that this protein might be as important in the causation of heart attack as are blood cholesterol levels.

In the most powerful and comprehensive study so far of associations of blood levels of CRP with major diseases (in an Article published Online First www.thelancet.com), Professor John Danesh at the University of Cambridge, UK, and 269 other scientists in the Emerging Risk Factors Collaboration (ERFC) combined information from 54 long-term medical surveys comprising over 160,000 people in 18 countries.

The researchers show that CRP concentration is associated with future risk of a wide range of common diseases, including: heart attack, stroke, deaths from various cancers, chronic lung disease, injuries, and other conditions. Most of the associations between CRP levels and heart disease were explained, however, by risk factors already known to cause heart disease (eg, smoking, blood pressure, obesity, cholesterol levels). This finding reduces the likelihood that CRP is a cause of heart disease.

The authors say: "Although our results support the idea that some process related to persistent inflammation is associated with vascular disease and other chronic disorders, most of the association with ischaemic vascular disease depends on conventional risk factors and fibrinogen concentration."

The authors conclude that further large studies are needed to assess other markers of inflammation, as well as their genetic and lifestyle determinants. They say: "Further work is also needed to assess whether evidence of low-grade inflammation mainly indicates external triggers (eg, socioeconomic position or infection), insulin resistance, hereditary predisposition, or some combination of such factors."

In an accompanying Comment, Dr S Matthijs Boekholdt and Professor John J P Kastelein, Academic Medical Center, Amsterdam, Netherlands, say: "One of the prominent topics in this debate is CRP's role in guiding decision-making for the primary prevention of cardiovascular disease. Current guidelines advise the use of established risk factors to quantify an individual's cardiovascular risk. These guidelines recommend that people at high risk should be treated, whereas for people at intermediate risk additional information should be obtained to guide decision-making. CRP measurement might be valuable in the fine-tuning of the choice of treatment in this specific subgroup... The wealth of data collected by ERFC will be an excellent source for future analyses to more accurately define the role of CRP in clinical decision-making."
-end-
Professor John Danesh, Emerging Risk Factors Collaboration, University of Cambridge, UK. T) +44 (0) 1223 741302 E) jd292@medschl.cam.ac.uk/erfc@phpc.cam.ac.uk

Dr S Matthijs Boekholdt, Academic Medical Center, Amsterdam, Netherlands. T) +31 20 566 6612 E) S.M.Boekholdt@amc.uva.nl

For full Article and Comment, see: http://press.thelancet.com/crp.pdf

Lancet

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.